Gos (Galactooligosaccharides) for Immune Function

Research suggests that galacto-oligosaccharides (GOS) may support immune function through several interconnected pathways, including promoting the growth of beneficial gut bacteria, increasing levels of anti-inflammatory signaling molecules, reducing pro-inflammatory markers, and supporting intestinal barrier integrity. The evidence base includes multiple randomized controlled trials in healthy older adults, overweight adults, and adults at risk for metabolic syndrome, as well as animal studies in piglets and calves, and a series of reviews synthesizing findings across infant nutrition and aging populations — the majority of which point in a supportive direction. Studies indicate that GOS may be particularly relevant for populations with heightened immune vulnerability, such as older adults experiencing age-related immune decline and newborns during critical windows of gut development, with proposed mechanisms running through microbiome modulation and the production of short-chain fatty acids. Some findings are mixed, however — one RCT noted simultaneous increases in both anti-inflammatory and pro-inflammatory markers such as C-reactive protein, and most of the clinical research relies on surrogate immune markers rather than direct disease outcomes, leaving the broader clinical significance of these effects still to be established.